1. Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J 1996;15(8):687-92.

2. Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. Viral Immunol 1995;8(1):47-52.

3. Nates S; Rey G; Giordano M; Medeot S; Depetris A; Boshell J; de Wolff CD. Immunoglobulin M antibody response to measles virus following natural virus infection, primary vaccination, and re-exposure to the virus. Viral Immunol 1997;10(3):165-73.

4. Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 1996; 97(5):653-7.

5. de Souza VA; Pannuti CS; Sumita LM; de Andrade J´unior HF. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J Med Virol 1997; 52(3):275-9.